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Abstract
Objectives To investigate the psychosocial impact of
bilateral prophylactic mastectomy for women with
increased risk of breast cancer and to identify,
preoperatively, risk factors for postoperative distress.
Design Prospective study using interviews and
questionnaire assessments.
Setting Participants’ homes throughout the United
Kingdom.
Participants 143 women with increased risk of
developing breast cancer who were offered bilateral
prophylactic mastectomy and who accepted or
declined the surgery; a further 11 were offered
surgery but deferred making a decision.
Main outcome measures Psychological and sexual
morbidity.
Results Psychological morbidity decreased
significantly over time for the 79 women who chose to
have surgery (accepters): 58% (41/71) preoperatively
v 41% (29/71) 6 months postoperatively (difference in
percentages 17%, 95% confidence interval 2% to 32%;
P = 0.04) and 60% (39/65) preoperatively v 29%
(19/65) 18 months postoperatively (31%, 15% to 47%;
P < 0.001). Psychological morbidity in the 64 women
who declined surgery (decliners) did not decrease
significantly: 57% (31/54) at baseline v 43% (23/54) at
6 months (14%, 0% to 29%; P = 0.08) and 57%
(29/52) at baseline v 41% (21/52) at 18 months (16%;
− 2% to 33%; P = 0.11). Greater than normal
proneness to anxiety was more common in the
decliners than in the accepters: 78% (45/58) v 56%
(41/73) (22%, 6% to 38%; P = 0.006). Accepters were
more likely than decliners to believe it inevitable that
they would develop breast cancer (32% (24/74) v 10%
(6/58) (difference in percentages 22%, 9% to 35%;
P = 0.003)), and decliners were more likely to believe
that screening could help (92% (55/60) v 74% (55/74)
(18%, 5% to 31%; P = 0.007)). Level of sexual
discomfort and degree of sexual pleasure did not
change significantly over time in either of the two
groups.
Conclusions Bilateral prophylactic mastectomy may
provide psychological benefits in women with a high
risk of developing breast cancer.
Introduction
Bilateral prophylactic mastectomy may significantly
reduce development of breast cancer in women at
increased risk,1 but as it is a radical surgical
intervention the psychological costs and benefits are
important to establish. Published reports tend to be
personal accounts of the decision to undergo surgery
or of living with the threat of the disease,2 3 or they are
case studies describing women’s reactions to the
impact of the disease on themselves and their family
and the difficulties they faced in decision making.4 5
One study reported that women’s decisions to have
prophylactic mastectomy were based on their biopsy
history, subjective perceptions of risk, and degree of
worry about cancer.6
Postoperative regret about having decided to
undergo surgery was reported in a retrospective study.7
The proportion of women expressing regret was small
(6% of 370 participants), and regret was more common
in those where discussion about the procedure was ini›
tiated by a physician, not the patient. Ninety per cent of
the women who regretted surgery had not received
preoperative counselling. Positive outcomes after bilat›
eral prophylactic mastectomy were reported in
another retrospective study, including favourable
psychological and social outcomes and decreased
emotional concern about developing the disease.8 To
date, little prospective research has been published in
large samples of women about the factors influencing
decision making or the psychosocial implications of
prophylactic surgery.
Important psychological benefits from surgery may
include a reduction in chronic anxiety and worry, in
distress associated with false positive mammography
results, and in dependence on screening and self
examination.9 For women who fear developing the dis›
ease, the putative psychological benefits of surgery may
well outweigh any negative consequences; none the
less, it is important to consider the psychological costs
and to examine the long term impact on women who
are offered the procedure but decline it.
We measured—by using interviews and question›
naire assessments—psychological morbidity in women
at increased risk of developing breast cancer who were
offered bilateral prophylactic mastectomy, regardless of
whether they accepted the option.
Cancer Research
Campaign
Psychosocial
Oncology Group,
Bland Sutton
Institute, Royal Free
and University
College Medical
School, London
W1P 7PL
Mal Bebbington
Hatcher
research psychologist
Lesley Fallowfield
professor of
psycho›oncology
Mulberry House,
Royal Marsden
NHS Trust, London
SW3 6JJ
Roger A’Hern
statistician
Correspondence to:
L Fallowfield
l.fallowfield@ucl.ac.uk
BMJ 2001;322:1–7
1BMJ VOLUME 322 13 JANUARY 2001 bmj.com
Method
Participants
Women at increased risk of developing breast cancer
were referred to us by clinicians (20 surgeons, 4 geneti›
cists, 4 medical oncologists, and 1 psychiatrist) working
in 20 participating centres throughout the United
Kingdom. Most referrals (54%) came from the North
West health region. All women gave written informed
consent to join the study, which had local and regional
ethics approval. Interviews and completion of ques›
tionnaires were conducted in the participants’ homes.
Eligibility criteria were having a family history of
breast cancer or having sufficiently high risk factors for
bilateral prophylactic mastectomy to be offered.
Genetic status was determined by the referring
clinicians. We did not know the risk level used by the
referring clinicians to select patients to be offered sur›
gery. Women reported being informed of their risk
either of carrying the gene or of developing the
disease. Most women in both groups (57% (42/74) of
those who chose to have surgery (accepters), 71% (41/
58) of those who declined surgery (decliners);
non›significant difference) reported a risk of carrying
the gene of between 1 in 2 and 1 in 4.
Of 168 women eligible to join the study, 7 declined
and 4 consented (but contact was lost with these 11
before they completed any assessments); a further 2
declined follow up assessments; and another was lost
to follow up after first interview. Of the 154 women
recruited to the study, 79 chose surgery, 64 declined,
and 11 deferred making a decision while awaiting
results of gene testing, completing their family, or seek›
ing further information. These 11 were not included in
any analysis.
Most women (73% (58/79) of accepters, 83%
(52/63) of decliners) were in paid occupations. The age
range was similar for both groups (26›57 (median 38)
years v 22›56 (40) years). Most women had children
(81% (64/79) v 75% (48/64)).
Women referred from specialist centres had had
access to geneticists (who conducted genetic assess›
ment and counselling) and to clinical psychologists or
psychiatrists for psychological counselling. Most
clinicians who referred women to the study, however,
were surgeons who had themselves assessed the risk
and provided risk counselling. Few of the women seen
by surgeons had been offered psychological counsel›
ling. The women referred by geneticists had often not
seen a surgeon at the time of first interview and did not
all have sufficient information about the surgery.
Ten women chose not to have reconstruction after
surgery. Sixty four had implants, two had tranverse rec›
tus abdominus muscle flaps, and one woman had a lat›
issimus dorsi flap on a breast that had previously been
operated on for cancer while an implant was placed in
the other breast. Details of postoperative complications
will not be known until a qualitative analysis of all
audiotaped interviews is complete. Decliners were
offered regular surveillance (mammography and clini›
cal examination).
Interviews
All women had their first interview as soon as possible
after they were referred to the study. The accepters
were interviewed again at 6 and 18 months postopera›
tively; the mean time from first interview until surgery
was 24 weeks (median 17 weeks, range 2 days to 125
weeks). Women who declined or deferred making a
decision were interviewed again 18 months after the
first interview. The interviews were semistructured, with
questions phrased to elicit information on decision
making, perceptions of risk, and psychosocial implica›
tions of surgery. Content analysis of transcribed tapes
is continuing and will be reported elsewhere.
Most women made their decision on whether to
have surgery at the time of the first interview,
regardless of whether they had seen a surgeon or felt
they had all the necessary information. A small minor›
ity changed their decision at a later date, on receipt of a
positive or negative blood test result.
Questionnaires
Six questionnaires were used in the study.
x The “general health questionnaire 30” was devel›
oped for use as a screening tool to determine psychiat›
ric morbidity in clinical or community settings.10 It has
excellent reliability and has been successfully validated
against the clinical interview schedule. It is a self
administered, 30 item questionnaire (with each item
rated on a 4 point scale).
x The “Spielberger state›trait anxiety inventory”
consists of two self administered, 20 item question›
naires, with each item rated on a 4 point scale.11 It is a
well researched clinical tool for evaluating current state
of anxiety (state) and proneness to anxiety (trait) and
has been successfully used in previous work with
women with breast cancer.12
x The “sexual activity questionnaire” was developed to
assess sexual functioning in the Tamoplac and IBIS
chemoprevention trials.13 14 The questionnaire has
test/retest reliability, and normative data from over 100
women aged between 30 and 65 from the general
population are available. The questionnaire comprises
three sections (hormonal status, reasons for sexual
inactivity, and sexual functioning) and has been factor
analysed into three scales (pleasure, discomfort, and
habit). It is currently being used in many other trials of
cancer therapy and seems acceptable to most women
to whom it has been administered, including patients
with advanced ovarian cancer.15
x The “ways of coping questionnaire” (revised) is a 66
item checklist devised to assess coping strategies used
to deal with a specific stressful event.16 The question›
naire items are rated on a 4 point, Likert›type scale.
The questionnaire has been factor analysed to predict
eight scales of coping strategies: problem focused;
detachment; wishful thinking; seeking social support;
focusing on the positive; self blame; tension reduction;
and keeping to self.
x The “risk perception questionnaire” contains five
questions that assess knowledge of risk.17 Analysis con›
sists of comparing risk estimates reported by women
with objective risk estimates and looking at the
frequency of risk values reported. This questionnaire
was used in a study examining the psychological
support needs of women at increased genetic risk of
breast cancer.18
x The “body image scale” is used to assess women’s
perception of their body image, applicable across
disease sites and treatment methods.19 The question›
naire has 10 items scored on a 4 point, Likert›type
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scale. The scale has been subjected to extensive
psychometric testing in the United Kingdom with data
provided by several centres.
All the questionnaires were administered to all
women at the first interview. At 6 months and 18
months after their first interview, the decliners
completed the general health questionnaire, the Spiel›
berger (state) questionnaire, and the sexual activity
questionnaire. At 6 months and 18 months postopera›
tively, the accepters completed these same three ques›
tionnaires, plus the body image scale.
Analysis
As the distributions of the outcome measures were fre›
quently skewed, non›parametric statistical tests were
used. The ÷2 test was used to compare differences in
proportions, except where the observations were
paired, in which case the McNemar test was used.
Paired, continuous observations were compared by
using the Wilcoxon test, and independent groups were
compared by using the Mann›Whitney U test.
Baseline statistical analysis included all women who
completed the assessment at the first interview. In sub›
sequent analyses, only those women who completed
assessments at each time point were included.
Ten women did not have a third interview; of these,
five had had their operation too late in the study to
have an 18 month postoperative interview, three had
moved too far away to make it financially feasible to
attend, and two were lost to follow up (despite intensive
efforts to trace them). These two women were lost to
follow up at a late stage and had therefore been
included in the earlier analysis.
Results
General health questionnaire
Table 1 shows the results from the general health ques›
tionnaire. The scores were compared over time within
and between the two groups. The proportion of
accepters scoring >4 (the threshold for possible
psychological morbidity, using the “GHQ” scoring sys›
tem10) reduced over time, both between the preopera›
tive (baseline) and the 6 month postoperative
assessment and between the preoperative and the 18
month postoperative assessment. Psychological mor›
bidity decreased significantly over time among the
accepters, and the longer the time from surgery, the
greater the decrease. The proportion of decliners scor›
ing >4 did not differ significantly between the first
(baseline) and the 6 month assessment. Over 50% of
decliners had psychological morbidity at the first
assessment, and this did not decrease significantly over
an 18 month period. No significant differences existed
between the two groups of women at any of the three
time points.
Spielberger state›trait anxiety inventory
The women’s scores for anxiety as a trait (tested at
baseline) were compared with published normative
values for women in this age group; a significantly
higher proportion of decliners than accepters were
prone to anxiety (table 2).
The women’s scores for anxiety at the time of
assessment (state anxiety) were compared with
published normative values for women in this age
group. Table 3 shows the results. The proportion of
accepters with anxiety above the normative score
decreased between the preoperative and the 6 month
postoperative assessment and between the preopera›
tive and the 18 month postoperative assessment.
Although anxiety levels were high among the
accepters, these decreased significantly over time, with
the decrease being greater the longer the time from
surgery (table 4). The proportion of decliners scoring
above the normative value did not differ significantly
between the baseline and the 6 month assessment and
the baseline and the 18 month assessment. Over 50%
of decliners were anxious, and their anxiety levels
remained high 18 months after the first assessment. No
significant differences in anxiety score existed between
the two groups of women at any of the three time
points.
Sexual activity questionnaire
Table 5 shows the results of the sexual activity
questionnaire. Sexual discomfort changed little over
time within or between groups, with median scores
being very close to the maximum of 6 (indicating no
discomfort). Among accepters, the median was 6 at all
times. Among decliners the median score did not
change significantly over the three time points. No sig›
nificant differences in sexual pleasure were found
between or within groups. Degree of sexual pleasure
did not change significantly over time in either of the
two groups.
Ways of coping questionnaire
Table 6 shows the results of the ways of coping
questionnaire. The median score for using problem
Table 1 Comparisons of percentages of women scoring >4 (threshold for possible psychological morbidity) on general health
questionnaire, based on numbers of women completing questionnaires at all relevant time points
Assessments
Accepters* Decliners†
% (proportion)
Difference (%)
(95% CI) P value % (proportion)
Difference (%)
(95% CI) P value
Baseline v 6 months 58 (41/71) v 41 (29/71) 17 (2 to 32) 0.04 57 (31/54) v 43 (23/54) 14 (0 to 29) 0.08
Baseline v 18 months 60 (39/65) v 29 (19/65) 31 (15 to 47) <0.001 57 (29/51) v 41 (21/51) 16 (−2 to 33) 0.11
CI=confidence interval.
*Women who had surgery.
†Women who declined surgery.
Table 2 Comparisons of percentages of women scoring above normative score of 35.6
(indicating anxiety proneness) on Spielberger trait anxiety questionnaire, and mean
scores
Surgery (n=73) Decliners (n=58)
Difference (%)
(95% CI) P value
% (No) of women 56 (41) 78 (45) 22 (6 to 38) 0.006
Mean score (range) 38 (35›42) 42 (37›49) 2 (−2 to 6) 0.36
The higher the score, the greater the proneness to anxiety.
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focused coping was significantly higher among accept›
ers than among decliners; the median score for using
detachment as a coping mechanism was significantly
higher among decliners than among accepters.
Body image scale
When the body image questionnaire was administered
postoperatively to the accepters (most of whom had
had immediate reconstruction) at the 6 and 18 month
interviews, no differences in the median score of 4
(range 0›30, with 0 indicating most positive body
image) were detected (median change 0, 95%
confidence interval 0 to 1; P = 0.84). Scores were simi›
lar to those published recently of women with breast
cancer who had immediate reconstruction.20
Risk perception questionnaire
Table 7 shows the women’s perceptions of personal
risk from breast cancer. Although most women in both
groups reported perceived risk levels of between 1 in 2
and 1 in 4, the accepters overall tended to report
higher lifetime risks of developing breast cancer than
the decliners. In particular, accepters were more likely
than decliners to believe it inevitable that they would
develop the disease. Decliners were more likely than
accepters to believe that screening could help (92%
(55/60) v 74% (55/74); difference in percentages 18%
(95% confidence interval 5% to 31%); P = 0.007).
Investigatory and genetic tests
Accepters were more likely than decliners to have had
an investigatory test (fine needle aspiration, biopsy, or
lumpectomy) (43% (34/79) v 19% (12/64); difference
in percentages 24% (10% to 39%); P = 0.002) or a gene
test (29% (23/79) v 5% (3/64); difference 24% (13% to
36%); P < 0.001).
Table 3 Comparisons of percentages of women scoring above normative score of 36.2 (indicating high anxiety) on Spielberger state
anxiety questionnaire, based on numbers of women completing questionnaires at all relevant time points
Assessments
Accepters Decliners
% (proportion)
Difference (%)
(95% CI) P value % (proportion)
Difference (%)
(95% CI) P value
Baseline v 6 months 69 (47/68) v 40 (27/68) 29 (15 to 44) <0.001 54 (26/48) v 54 (26/48) 0 (−13 to 13) 1.00
Baseline v 18 months 71 (45/63) v 41 (26/63) 30 (14 to 46) 0.001 52 (24/46) v 50 (23/46) 2 (−11 to 15) 1.00
The higher the score, the greater the anxiety.
Table 4 Comparisons of women’s raw scores on Spielberger state anxiety questionnaire, based on numbers of women completing
questionnaires at all relevant time points
Assessments
Accepters Decliners
Median score
Median difference
(95% CI) P value Median score Median difference (95% CI) P value
Baseline v 6 months 45.3 v 32 4 (2.2 to 10) <0.001 38.5 v 37 0.5 (−3 to 4) 0.44
Baseline v 18 months 43.5 v 33 6 (2 to 10) <0.001 38.5 v 36 1 (−3 to 2) 0.27
The higher the score, the greater the anxiety.
Table 5 Median scores for sexual discomfort* and sexual pleasure† over time
Assessments
Accepters (n=45) Decliners (n=34)
Score
Median difference (95%
CI) P value Score
Median difference
(95% CI) P value
Sexual discomfort:
Baseline v 6 months 6 v 6 0 (0 to 0) 0.93 5 v 6 0 (0 to 0) 0.75
Baseline v 18 months 6 v 6 0 (0 to 0) 0.56 5 v 5.5 0 (0 to 0) 0.41
Sexual pleasure:
Baseline v 6 months 13.5 v 14 0 (−1 to 2) 0.44 12.5 v 15 0 (−1 to 0) 0.50
Baseline v 18 months 13.5 v 14 0 (−1 to 1) 0.69 13.5 v 13.5 0 (−1 to 0) 0.65
*Scale of 0 to 6 (6=no discomfort). †Scale of 0 to 18 (18=high sexual pleasure).
Table 6 Median scores* for problem focused and detachment coping styles, according
to results of ways of coping questionnaire
Coping style Accepters (n=75) Decliners (n=59)
Median difference
(95% CI) P value
Problem focused 16 14 3 (0 to 5) 0.03
Detachment 3 7 3 (2 to 5) <0.001
*A higher score indicates more use of the coping style.
Table 7 Women’s personal risk estimates from risk perception questionnaire:
percentage frequency of answers to question, “What do you think is your lifetime risk
of developing breast cancer?”
Risk estimate
Percentage frequency
Accepters (n=74) Decliners (n=57)
Inevitable 32 10
80% 3 0
1 in 2 27 19
1 in 3 20 35
1 in 4 10 17
1 in 5 1 2
1 in 6 1 4
1 in 8 0 2
1 in 10 3 2
1 in 12 0 4
1 in 20 1 0
1 in 50 0 5
1 in 100 1 0
Comparison of inevitable v not inevitable, P=0.001.
Mann›Whitney test for trend over all categories, P<0.005.
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Discussion
Our primary aim was to evaluate the psychosocial
impact of bilateral prophylactic mastectomy by
comparing psychological morbidity in women who
have had the procedure with women who have been
offered but declined the procedure. High levels of psy›
chological morbidity and anxiety before surgery
reduced significantly over time after surgery. In women
who declined surgery and opted for regular surveil›
lance and screening, high levels of psychological mor›
bidity and anxiety were maintained.
Our results are concordant with those from a US
study which hypothesised that bilateral prophylactic
mastectomy reduced chronic anxiety and worry, while
women attending a family history clinic but not
participating in any other prevention programme had
increased anxiety.9 Conversely, other authors reported
that 24 women with a family history who did not attend
a family history clinic had significantly higher anxiety
scores than 47 women with a family history who were
attending a clinic and participating in a chemopreven›
tion trial comparing tamoxifen with placebo.21 These
authors surmised that participation in a prevention
programme, or attendance at a specialist clinic,
alleviated anxiety.
In our study the women who declined surgery had
significantly higher scores for anxiety as a personality
trait than those who had surgery, which may explain
why the high levels of anxiety and psychological mor›
bidity among decliners did not decrease over time. The
women who declined also tended to use detachment to
cope, rather than the problem focused approach used
more frequently by those who had surgery. The
statements reflecting use of detachment (such as “I try
to forget the whole thing”) are much more passive than
the problem focused statements (such as “I’m making a
plan of action and following it”). Although they seemed
to be more anxious, the women who declined surgery
were less inclined to act on their anxiety.
It is encouraging to note that the women who had
surgery (most of whom had had immediate recon›
struction) maintained a positive body image and
reported few or no changes in sexual activity at each
time point, although longer follow up studies are
needed.
Further research is also needed to look at the best
method of ensuring that risk perception is accurate. A
recent study found that genetic counselling produced
only a modest shift in the accuracy of perceived
lifetime risk.22 We found that 32% of women who had
surgery believed it inevitable that they would develop
breast cancer. If women are making decisions based on
inaccurate perceptions they might regret these
decisions later. Although our study found no evidence
for this up to 18 months after surgery, future research
needs to include a longer follow up. Inaccurate percep›
tions of lifetime risk, coupled with the greater number
of investigatory tests, confirms another report that
women choosing surgery had undergone more
biopsies and reported higher risk estimates than those
who declined.6 In another study of women at high
genetic risk, entry into a chemoprevention trial was
higher in women who believed themselves to be at
greater personal risk.23
Conclusion
Women who chose to have surgery strongly believed
that removal of breast tissue would significantly reduce
their chances of developing the disease. The fact that
such a high percentage of these women believed that
they would inevitably develop cancer may explain both
their decision to have the prophylactic surgery and
their reduction in anxiety and psychological morbidity
postoperatively.
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